Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This activity is supported by an educational grant from Bristol Myers Squibb.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Bristol Myers Squibb.
Activity Description
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. The condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap in the understanding of racial/ethnic and gender-based disparities persists among healthcare professionals. This gap influences the diagnosis and management of HCM and its subtype, cardiac amyloidosis (which includes transthyretin cardiac amyloidosis and light-chain cardiac amyloidosis). It also contributes to underdiagnosis or delayed diagnosis, resulting in increased healthcare use and suboptimal patient outcomes.
This CE program is designed for healthcare professionals seeking to enhance their understanding and ability to provide equitable care for patients with HCM, thereby improving patient outcomes and addressing healthcare disparities. This monograph provides a patient advocacy point of view and discusses screening strategies, differential diagnosis and management of clinical cases, and targeted treatments and also reviews the drivers of racial/ethnicity-based disparities in HCM care.
Target Audience
The intended audience for this activity is cardiologists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients with, or at risk for, hypertrophic cardiomyopathy (HCM).
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Utilize appropriate diagnostic approaches to identify patients with HCM.
- Recognize racial/ethnic and gender-based disparities in the management of HCM.
- Apply the latest clinical evidence for the safety and efficacy of current and emerging treatment options for patients with HCM.
Activity Chair
Melissa Suzanne Burroughs, MD, MS, FACC
Cardiologist
Wellstar Center for Cardiovascular Care
Marietta, GA
Faculty
Monica Ahluwalia, MD, FACC
Director, Hypertrophic Cardiomyopathy Program at Boston Medical Center
Assistant Professor, Boston University Chobanian & Avedisian School of Medicine
Staff Physician, Boston Medical Center
Staff Physician, Brigham & Women’s Hospital
Boston, MA
Jacques Kpodonu, MD, FACC
Thoracic and Cardiac Surgery
Scientist
Beth Israel Deaconess Medical Center
Boston, MA
Patient Advocate
Lisa Salberg
Founder and CEO
Hypertrophic Cardiomyopathy Association
Denville, NJ
Patient
Avonne White
Medical Writer
Valerie Zimmerman, PhD
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C
Barbara A. Niedz, PhD, RN, CPHQ
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.
Vindico Medical Education will provide a maximum of 1.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.75 AAPA Category 1 CME credits. Approval is valid until 9/14/2025. PAs should only claim credit commensurate with the extent of their participation.
This enduring material is approved for 1 year from the date of original release, September 15, 2024, to September 14, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™certificate, AAPA Category 1 CME certificate, or contact hour certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Ahluwalia, Burroughs, and Kpodonu and Ms. Salberg during a live virtual webinar held on June 5, 2024. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Monica Ahluwalia, MD, FACC
Consultant: Bristol Myers Squibb
Melissa Suzanne Burroughs, MD, MS, FACC
Advisor: Bristol Myers Squibb
Independent Research Contractor: Cytokinetics
Jacques Kpodonu, MD, FACC
No relevant financial relationships to disclose.
Patient Advocate reports the following relevant financial relationship(s)
Lisa Salberg
No relevant financial relationships to disclose.
Patient reports the following relevant financial relationship(s)
Avonne White
No relevant financial relationships to disclose.
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com